11:05 AM EST, 01/02/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving higher late Thursday morning, rising 0.57% to 1,294.83 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company VEON (VEON) and biotech firm Evaxion Biotech ( EVAX ) , which climbed 7.3% and 6.3% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and biopharmaceutical company Genfit ( GNFT ) , which rose 3.7% and 2.9% respectively.

The decliners from continental Europe were led by financial services companies Banco Bilbao Vizcaya Argentaria ( BBVA ) and Banco Santander (SAN), which fell 2.2% and 1.8% respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and software firm SAP (SAP), which dropped 1.7% and 0.6% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) , which advanced 15%, followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which rose 13% each. They were followed by biopharmaceutical company Amarin ( AMRN ) , which increased 9.3%.

The decliners from the UK and Ireland were led software firm by Endava ( DAVA ) and financial services company HSBC ( HSBC ) , which lost 1.3% and 1% respectively. They were followed by alcoholic beverages company Diageo ( DEO ) and biopharmaceutical company TC Biopharm ( TCBP ) , which were off 0.8% and 0.5% respectively.